Back to Transactions
Healthcare
2014

Eschenbach has sold its technical optics division to BWK

Client: Eschenbach

Client Location: Germany

Target: Technical optics division of Eschenbach (Optoflux GmbH)

Target Location: Germany

Buyer: BWK

Buyer Location: Germany

Target Description: Producer of injection molded plastic and silicone lenses for use in automotive lighting, photonics and LED lighting as well as production of vision aids and magnification devices.

Eschenbach Optics Division BWK 2014

Related
Perspectives

Connect with a Senior Team Member

Meet our Senior Team

Friedrich Bieselt
I am enthusiastic about creating sustainable growth and the highest value for our clients and strive to leave a positive footprint beyond any successful M&A transaction.

Friedrich Bieselt

Managing Director & Head of Business Services, Europe

Frankfurt

Dirk Engelmann
I am enticed by the dynamics of M&A deals in combination with learning and understanding companies' business models and striving to achieve the best outcome for clients.

Dirk Engelmann

Managing Director

Frankfurt

View More Transactions in Healthcare

Lincoln International advised Gilde Healthcare and Capital A Investment Partners on refinancing Tromp Medical

Healthcare

Lincoln International advised H.I.G. Growth on completing a significant growth investment in Carebox

Healthcare | Technology

Lincoln International advised Crédit Mutuel Equity on the sale of Technoflex to Adagia Partners

Healthcare

Lincoln International advised UPSA on the acquisition of Sérélys Pharma

Healthcare

Lincoln International advised Phoenix Equity Partners in completing a multi-asset continuation vehicle transaction involving Nineteen Group and Envisage Dental

Healthcare

Lincoln International advised OceanSound Partners on the acquisition of PAR Excellence from Northlane Capital Partners

Healthcare

Lincoln International advised Audax Private Equity on the sale of Chartis to Blackstone Growth

Business Services | Healthcare

Lincoln International advised Hobson & Motzer on its sale to Vantedge, a portfolio company of Aterian

Healthcare
View All

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.